Skip to content

What are the benefits of vitamin K2? Evidence, claims & uses

Published · Updated · By Tigoo redaktionSupplements

Short answer

Vitamin K2 is best supported for improving vitamin K status markers in blood, especially osteocalcin and matrix Gla protein. The available trials do not prove disease prevention or treatment, and the strongest evidence is for biomarker shifts rather than hard clinical outcomes.

Quick facts

  • MK-7 improved osteocalcin carboxylation in 12-week adult trials.
  • Higher MK-7 doses reduced dp-ucMGP by about 31% and 46%.
  • Natto is the richest verified food source, with about 850 µg MK-7 per 3 oz serving.
  • Most common animal foods listed provide only single-digit micrograms per serving.
  • MK-7 has a longer half-life, and both MK-4 and MK-7 are well absorbed.
  • Vitamin K products are often combined with vitamin D, calcium or magnesium.
What are the benefits of vitamin K2? Evidence, claims & uses

What are the proven benefits of vitamin K2?

In adults, the clearest benefit seen in the retrieved trials is better vitamin K status on blood markers linked to bone and vascular proteins, not proof of disease prevention. In a double-blind trial of 120 Japanese adults aged 20-69, 100 µg/day of MK-7 for 12 weeks increased the carboxylated-to-undercarboxylated osteocalcin ratio. In adults aged 40-65, 180 µg/day and 360 µg/day of MK-7 for 12 weeks reduced dp-ucMGP by about 31% and 46% and improved the osteocalcin ratio by 60% and 74%.

What that looks like in practice

Those numbers matter because they show that vitamin K2 can change the biochemical markers people use to track vitamin K-dependent proteins.

StudyPopulationMK-7 intakeWhat changed
12 weeks120 Japanese adults, 20-69 years100 µg/dayOsteocalcin carboxylation marker improved (PubMed)
12 weeksAdults, 40-65 years180 µg/day and 360 µg/daydp-ucMGP fell by about 31% and 46%; osteocalcin ratio improved by 60% and 74% (PubMed)

Where the hard-outcome evidence stops

These studies do not show vitamin K2 as a treatment for heart disease, dementia, cancer, or performance. Even in hemodialysis patients, 360 µg of MK-7 three times per week for 18 months did not produce a statistically significant difference in coronary artery calcium progression. So the strongest evidence is for biomarker shifts, while clinical outcomes remain unproven or mixed.

Vitamin K2 is best supported as a nutrient that improves vitamin K status markers, not as a proven disease therapy.

How does vitamin K2 work in the body?

Vitamin K2 is discussed in the studies here as menaquinone-4 (MK-4) and menaquinone-7 (MK-7). The NIH fact sheet says both are well absorbed, while MK-7 has a longer half-life (NIH Office of Dietary Supplements: Vitamin K fact sheet). In practice, that means researchers can track how each form changes blood markers after intake, rather than guessing from the label alone.

How does vitamin K2 work in the body?
Vitamin K2 is discussed in the studies here as menaquinone-4 (MK-4) and menaquinone-7 (MK-7).

Carboxylation is the key biochemical step

The marker changes most often measured are osteocalcin and matrix Gla protein (MGP). After MK-7 supplementation, Japanese adults taking 100 µg/day for 12 weeks showed a higher carboxylated-to-undercarboxylated osteocalcin ratio, which is the blood sign that vitamin K-dependent protein carboxylation has shifted upward (PubMed: low-dose daily vitamin K2 and osteocalcin γ-carboxylation). In adults aged 40 to 65, 180 µg/day and 360 µg/day MK-7 for 12 weeks reduced dephosphorylated-uncarboxylated MGP by about 31% and 46%, respectively, with both doses also improving the osteocalcin ratio (PubMed: menaquinone-7 and circulating matrix Gla protein species).

That matters because the studies are following two different protein pools: osteocalcin on the bone side and MGP on the vascular side. The evidence provided links the carboxylated forms to bone mineralisation and to limiting inappropriate calcium deposition in soft tissues, so the blood-marker changes are the cleanest way to see the mechanism in action.

MK-4 and MK-7 behave differently in supplements

FormHuman study contextWhat changed in blood
MK-445 mg/day for 2 weeks in elderly women with osteoporosisSerum MK-4 rose from about 0.20 to 15.09 pg/mL
MK-7100 µg/day for 12 weeks in Japanese adultsCarboxylated-to-undercarboxylated osteocalcin ratio increased
MK-7180 µg/day or 360 µg/day for 12 weeks in adults aged 40 to 65dp-ucMGP fell by about 31% and 46%

A fortified yogurt drink delivering 28 µg MK-7 twice daily, or about 56 µg/day, raised plasma MK-7 from 0.28 to 1.94 ng/mL, and yogurt matrices produced greater plasma MK-7 increases than capsules over 42 days; both lowered dp-ucMGP and ucOC (PubMed: fortified yogurt drink with menaquinone-7; PubMed: steady-state MK-7 after dairy products and soft-gel capsules).

Key takeaway: the most concrete biochemical effect of vitamin K2 in human studies is a shift toward more carboxylated osteocalcin and MGP in blood, with MK-7 and MK-4 showing different absorption patterns and circulating levels.

What the evidence does and does not show

The mechanism is clear at the biomarker level; the harder question is whether that translates into meaningful changes in bone or vascular health in everyday use.

What do the research and authorised claims say?

EFSA’s vitamin K opinion says vitamin K plays an important role in blood coagulation and bone mineralisation, and it set adequate intakes for adults at 70 µg/day for vitamin K overall, not for K2 specifically. EFSA vitamin K opinion

What the trials actually measured

PopulationVitamin K2 form and doseWhat changedWhat did not change
120 Japanese adults, age 20–69MK-7, 100 µg/day for 12 weeksOsteocalcin carboxylation improvedNo fracture endpoint was reported
148 postmenopausal womenMK-7, 375 µg/day plus calcium and vitamin D for 12 monthsSerum ucOC fell by about 70% versus about 7% in placebo; adiponectin rose about 6.1%Insulin sensitivity was unchanged
Patients with type 2 diabetes and cardiovascular diseaseMK-7, 360 µg/day for 6 monthsdp-ucMGP fell by about 205 pmol/LVascular calcification did not decrease by PET or CT
Chronic dialysis patientsMK-7, 360 µg/day for 2 yearsLumbar spine BMD was preserved; mean difference versus placebo +0.050 g/cm²Distal radius BMD declined more; mean difference −0.023 g/cm²; other sites were unchanged

Biomarkers are not the same as clinical endpoints

The pattern across these studies is clear: K2 changes markers of vitamin K status, including osteocalcin and matrix Gla protein carboxylation, but the trials stop short of proving the headline outcomes people usually want. In the diabetes and cardiovascular disease study, dp-ucMGP improved while vascular calcification did not; in dialysis, one bone site improved while another worsened. Those are mixed results, not a clean whole-body effect. MK-7 and osteocalcin carboxylation MK-7 and vascular calcification MK-7 and dialysis bone density

The evidence here is strongest for biomarker shifts, weaker for bone density outside select settings, and not convincing for fracture reduction or vascular calcification reduction.

What K2 does best in the available trials is move biomarkers; what it has not yet shown reliably is a hard clinical benefit.

Which foods provide vitamin K2?

Natto is the richest verified source

The clearest natural source in the evidence is natto, a fermented soy food. The NIH Vitamin K Health Professional Fact Sheet lists about 850 µg of MK-7 per 3 oz serving, which is far above the amounts reported for common animal foods.

Which foods provide vitamin K2?
The clearest natural source in the evidence is natto , a fermented soy food.

In food tables, vitamin K2 appears mainly as menaquinone-4 (MK-4) in animal foods and MK-7 in natto. The same NIH fact sheet also notes that amounts in animal foods can vary with feed fortification and fermentation conditions, so composition data should be read as approximate rather than fixed numbers. NIH Vitamin K Health Professional Fact Sheet

Animal foods usually provide smaller MK-4 amounts

Chicken, beef, cheese and eggs all show up in the NIH table, but typically in single-digit micrograms per serving. A separate USDA menaquinone file gives additional item-level figures for cooked beef dishes, which is useful because different databases do not always list the same foods or serving formats. USDA menaquinone food database

FoodTypical servingApprox. vitamin K2Main formSource
Natto3 oz850 µgMK-7NIH
Chicken breast, rotisserie3 oz13 µgMK-4NIH
Ground beef, broiled3 oz6 µgMK-4NIH
Cheddar cheese1½ oz4 µgMK-4NIH
Hard-boiled egg1 large4 µgMK-4NIH
Beef pot pie, cooked268 g5.9 µgMK-4USDA

Why the numbers move around

Fermentation and the food matrix matter. In one study, a yogurt drink fortified with 28 µg MK-7 twice daily raised plasma MK-7 from 0.28 to 1.94 ng/mL, and another trial found yogurt matrices produced larger plasma MK-7 increases than capsules over 42 days. Those studies are not food-composition tables, but they show why the same vitamin K2 form can behave differently depending on how the food is made. Yogurt drink fortified with menaquinone-7 Steady-state vitamin K2 after dairy products and capsules

Natto is the standout food source; most other everyday foods in the verified tables provide much smaller MK-4 amounts.

If you are checking labels or comparing foods, focus on the named form and the serving size, not just the word “K2.”

What are vitamin D3 benefits, and how does K2 fit?

What D3 is supported to do

NIH’s vitamin D fact sheet says adults are advised to consume recommended amounts of vitamin D and calcium to maintain bone health and possibly prevent osteoporosis, and it highlights bone health especially in older adults. Vitamin D Health Professional Fact Sheet Vitamin D Consumer Fact Sheet

For shoppers, that is the clearest evidence-based case for D3: it is the vitamin people check when the goal is to keep bone-related intake on track, especially when a deficiency is suspected or confirmed.

Why D3 and K2 are often paired

NIH notes that vitamin K is often combined with calcium, magnesium and/or vitamin D in supplements. That explains why D3 and K2 are frequently sold together, but it does not create an authorised claim that the combination is a universal fix for bone health. Vitamin K Health Professional Fact Sheet

NutrientWhat the cited sources supportWhat not to assume
Vitamin D3Bone health with calcium; deficiency-related rickets or osteomalacia; muscle strengthThat K2 is required for D3 to be useful
Vitamin K2Commonly paired with vitamin D in supplementsThat the pairing proves extra benefit on its own

What to check before buying a D3+K2 product

If a product combines the two, check that the vitamin D amount is stated separately from K2 and that the label does not imply one nutrient can replace the other. EFSA’s vitamin K opinion also says the data for menaquinones are insufficient to derive reference values specifically for K2. EFSA Scientific Opinion on Dietary Reference Values for vitamin K

Pairing D3 with K2 is common on supplement labels, but the supplied sources do not turn that pairing into a universal bone-health claim.

What are the benefits of vitamin B2?

Riboflavin is a different nutrient from vitamin K2. That is the clearest reason it appears alongside vitamin K2: it belongs to a separate vitamin system and does not do the same biochemical job.

What are the benefits of vitamin B2?
Riboflavin is a different nutrient from vitamin K2.

What riboflavin does best

In practical terms, that means B2 is mainly about keeping core cellular chemistry and tissue maintenance working normally, not about acting like vitamin K2.

VitaminMain role in the retrieved evidenceWhat it is not replacing
Riboflavin (vitamin B2)Vitamin K2’s role in the vitamin K pathway
Vitamin KVitamin K contributes to normal blood clotting and maintenance of normal bonesRiboflavin’s coenzyme role in metabolism

EFSA’s vitamin K opinion places vitamin K in the context of blood coagulation and bone mineralisation, while riboflavin sits in a different biochemical lane (EFSA vitamin K advice).

Where the evidence is more limited

Outside deficiency, the evidence is much less firm. A Cochrane review on riboflavin supplements for blood pressure lowering in adults found the evidence very uncertain, and a Nordic scoping review said current studies do not firmly support changing riboflavin dietary recommendations (Cochrane review on riboflavin and blood pressure; Nordic scoping review). A broader review also discusses possible antioxidant, neuroprotective and migraine-related uses, but those topics sit on a separate evidence base from vitamin K2 and should not be read as the same kind of claim (riboflavin review in human health).

Riboflavin is useful to compare with vitamin K2, but it is not a substitute: B2 works through FMN and FAD in metabolism, while vitamin K works in clotting and bone-related pathways.

Bottom line for shoppers

If a multivitamin contains both vitamins, that does not mean they overlap.

How do you choose a vitamin K2 supplement?

Start with the Supplement Facts panel. FDA’s dietary supplement labeling guide says the panel must list the names and quantities of dietary ingredients, so a K2 product should show the exact ingredient name and the amount per serving rather than leaving you to infer it from the front of the pack FDA Dietary Supplement Labeling Guide.

Check the exact menaquinone form

“Vitamin K2” is too vague for careful comparison shopping. The supplement literature includes both menaquinone-4 (MK-4) and menaquinone-7 (MK-7), so the label should name the exact form instead of hiding it behind a generic K2 claim PubMed: MK-4 study PubMed: MK-7 study.

FormWhat to look for on the labelWhy it helps
MK-4“menaquinone-4 (MK-4)” or an equivalent exact formLets you see which menaquinone you are actually buying FDA Dietary Supplement Labeling Guide
MK-7“menaquinone-7 (MK-7)” or an equivalent exact form

Read the amount, the carrier, and whether it is combined

If the product is combined with vitamin D3, calcium, or magnesium, the label should still let you see each ingredient clearly. NIH notes that vitamin K supplements are often combined with calcium, magnesium and/or vitamin D, but that fact alone does not prove a special extra benefit; it simply means the formula needs a careful read NIH Vitamin K fact sheet.

Use source wording and transparency as extra checks

FDA allows the source of a dietary ingredient to be listed in the Supplement Facts panel, so source wording can help you decide whether a product matches your preference for a fermentation-derived ingredient or another source declaration FDA Dietary Supplement Labeling Guide. If a brand also supplies third-party testing or batch documentation, treat that as an added check, not a substitute for a complete label.

If the label or technical sheet mentions all-trans MK-7, treat it as extra transparency.

Choose the exact form, the microgram amount, and the full formula details before you compare price.

Two bottles can look similar and still differ in the menaquinone subtype, whether K2 is standalone or combined with other nutrients, and how clearly the source is declared on the panel.

Who should avoid vitamin K2 or get medical advice first?

Warfarin and other vitamin K antagonists

Vitamin K, including vitamin K2, can interfere with vitamin K antagonist therapy.

Do not start, stop, or change vitamin K2 on your own if you take warfarin or a similar vitamin K antagonist.

When a clinician should review K2 first

EFSA’s 2017 advice sets an adequate intake of 70 µg/day for adults, including pregnant and lactating women, and EFSA’s UL summary table lists vitamin K as having “no adequate data to derive a UL” EFSA vitamin K advice EFSA UL summary tables.

What to do before changing a supplement

SituationWhy to ask firstPractical step
Warfarin or another vitamin K antagonistChanges in vitamin K intake can alter anticoagulation control NIH Vitamin K fact sheet.Keep intake consistent and ask before changing vitamin K2.
Malabsorption or post-bariatric surgeryFat-soluble vitamin absorption can be reduced NIH Vitamin K fact sheet.Ask whether supplementation is appropriate for you.
Pregnancy or breastfeedingEFSA gives an adult adequate intake of 70 µg/day, but no UL is established EFSA vitamin K advice EFSA UL summary tables.Get advice before using high-dose supplements.

Safety and precautions

Do not start, stop, or change vitamin K2 on your own if you take warfarin or another vitamin K antagonist, because vitamin K can affect anticoagulation control. If you have malabsorption or have had bariatric surgery, ask a clinician before using K2.

Speak to a healthcare professional before use if you are pregnant, breastfeeding, or giving a supplement to a child. Get individual advice before using high-dose vitamin K2 or changing your supplement routine.

Supplements with the ingredients in this article

Compare contents, dose and price

Frequently asked questions

What is the difference between vitamin K1 and vitamin K2?

This article focuses on vitamin K2 rather than K1, so it does not give a detailed side-by-side comparison. The body describes K2 as MK-4 and MK-7, notes that both are well absorbed, and says MK-7 has a longer half-life.

Is vitamin K2 vegan?

The body does not say that vitamin K2 is always vegan. It mentions natto as a fermented soy food, animal foods as sources of MK-4, and says label source wording can help you judge whether a product matches a fermentation-derived preference. So whether a product is vegan depends on the exact ingredient source.

What does all-trans MK-7 mean on a label?

It is a more specific way to describe the MK-7 ingredient, but you should still check the exact form, the amount, and the source.

Can you get enough vitamin K2 from a normal Western diet?

The body suggests that typical Western foods usually provide only small amounts of K2, with chicken, beef, cheese, and eggs generally listed in single-digit micrograms per serving. Natto is much richer than those foods, and the body does not define exactly how much K2 is enough from a Western diet.

Can vitamin K2 be taken with food or with a multivitamin?

Yes. The body describes K2 in fortified yogurt and in capsules, and it says vitamin K is often combined with vitamin D, calcium, or magnesium in supplements. The key is to check the label so the exact K2 form and amount are clear.

Sources

  1. Low-Dose Daily Intake of Vitamin K(2) (Menaquinone-7) Improves Osteocalcin γ-Carboxylation: A Double-Blind, Randomized Controlled Trials - PubMed (external link)
  2. Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis - PubMed (external link)
  3. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein - PubMed (external link)
  4. Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial - PubMed (external link)
  5. Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK) - PubMed (external link)
  6. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial - PubMed (external link)
  7. Vitamin K2 (menaquinone-7) increases plasma adiponectin but does not affect insulin sensitivity in postmenopausal women: a randomized controlled trial - PubMed (external link)
  8. Yogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population - PubMed (external link)
  9. Steady-state vitamin K2 (menaquinone-7) plasma concentrations after intake of dairy products and soft gel capsules - PubMed (external link)
  10. Scientific Opinion on Dietary Reference Values for vitamin K (external link)
  11. USDA National Nutrient Database for Standard Reference Release 28 December 16, 2015 04:14 EST (external link)
  12. Vitamin D - Health Professional Fact Sheet (external link)
  13. 2 • VITAMIN D FACT SHEET FOR CONSUMERS (external link)
  14. Riboflavin in Human Health: A Review of Current Evidences - PubMed (external link)
  15. Riboflavin supplements for blood pressure lowering in adults. (external link)
  16. Riboflavin: a scoping review for Nordic Nutrition Recommendations 2023 - PubMed (external link)
  17. Riboflavin Deficiency - PubMed (external link)
  18. Vitamin K - Health Professional Fact Sheet (external link)
  19. Version 10 (June 2024) (external link)
  20. Dietary reference values: EFSA publishes advice on vitamin K | EFSA (external link)
  21. Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling | FDA (external link)

Read more

Products related to this article

More in Supplements